Protalix BioTherapeutics, Inc. Stock TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 190M 57.79B 167M 154M 142M 270M 18.06B 275M 1.84B 716M 8.91B 714M 698M 30.83B | P/E 2026 * |
12.1x | P/E 2027 * | 47.2x |
|---|---|---|---|---|---|
| Enterprise Value | 190M 57.79B 167M 154M 142M 270M 18.06B 275M 1.84B 716M 8.91B 714M 698M 30.83B | EV / Sales 2026 * |
2.43x | EV / Sales 2027 * | 2.81x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 58 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 58 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 58 | 2019-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 185M | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,070B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 624B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 198B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 161B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 135B | |
| Average | +0.78% | +2.20% | +26.94% | +53.47% | 385.27B | |
| Weighted average by Cap. | +0.29% | +2.51% | +41.85% | +87.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 23.8B 68.64M 63.31M 58.64M 111M 7.43B 113M 758M 295M 3.67B 294M 288M 12.69B | 67.56M 20.54B 59.23M 54.63M 50.61M 95.96M 6.42B 97.57M 654M 254M 3.16B 254M 248M 10.95B |
| Net income | 15.72M 4.78B 13.78M 12.71M 11.78M 22.33M 1.49B 22.71M 152M 59.22M 736M 59.03M 57.74M 2.55B | 4.07M 1.24B 3.57M 3.29M 3.05M 5.79M 387M 5.88M 39.44M 15.34M 191M 15.29M 14.96M 660M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
